Skip to content
All news
Earnings

ExxonMobil Q1 2026 EPS Beats Estimates by 15%, Revenue Hits $85.1B

ExxonMobil (NYSE: XOM) kicked off energy sector earnings with a strong profit beat, posting adjusted EPS of $1.16 versus the $1.0074 consensus, a 15.15% upside surprise. Revenue came in at $85.138 billion, though GAAP figures were impacted by derivative timing effects and Middle East supply disruptions.

May 4, 2026
2 min read
Source: 24/7 Wall St.
Share:

Key Numbers

adjusted eps
1.16
consensus eps
1.0074
revenue
85.138B
eps beat percent
15.15%

ExxonMobil (NYSE: XOM) opened the energy sector's earnings season with a sharp upside surprise on profitability, even as headline GAAP figures were dragged lower by derivative timing effects and Middle East supply disruptions. The integrated major posted adjusted EPS of $1.16 versus the $1.0074 consensus, a 15.15% beat, while revenue of $85.138 billion came in.

Key Financial Results

MetricValue
Revenue$85.138 billion
Adjusted EPS$1.16
Consensus EPS$1.0074
Beat Percentage15.15%

Highlights from the Release

The company attributed the strong performance to improved refining margins and increased production from key projects, despite geopolitical disruptions. Derivative timing effects negatively impacted GAAP results.

Future Guidance

No specific numerical guidance was provided for the next quarter, but the company expects continued strong demand for oil and gas.

Impact on Stock

The strong earnings beat is likely to bolster investor confidence in XOM, especially amid volatile oil prices.

What This Means for Investors

ExxonMobil's Q1 performance demonstrates its ability to outperform expectations despite challenges, reinforcing its position as a resilient investment in the energy sector.

Frequently Asked Questions

Adjusted EPS was $1.16, beating the consensus estimate of $1.0074.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.